Published in AMA Arch Neurol Psychiatry on February 01, 1954
Effects of largactil in mental syndromes. Can Med Assoc J (1954) 2.81
Effect of chlorpromazine on the behavior of chronically overactive psychotic patients. Br Med J (1954) 1.71
A theoretical examination of double-blind design. Can Med Assoc J (1967) 1.49
Adynamic ileus during psychoactive medication: a report of three fatal and five severe cases. Can Med Assoc J (1967) 1.40
Fifty years chlorpromazine: a historical perspective. Neuropsychiatr Dis Treat (2007) 1.25
Comparison of the effects of promazine and chlorpromazine in mental syndromes. Can Med Assoc J (1957) 1.23
Therapeutic results with chlorpromazine (largactil) in psychiatric conditions. Can Med Assoc J (1955) 1.17
Group II metabotropic glutamate receptors and schizophrenia. Cell Mol Life Sci (2009) 1.04
Seizures occurring during intensive chlorpromazine therapy. Can Med Assoc J (1956) 0.92
Liver damage and eosinophilia following chlorpromazine therapy; report of a case. Br Med J (1955) 0.92
The occurrence of epileptic fits in leucotomized patients receiving chlorpromazine therapy. J Neurol Neurosurg Psychiatry (1957) 0.87
Chlorpromazine alone and with reserpine; use in the treatment of mental diseases. Calif Med (1955) 0.86
Chlorpromazine jaundice in a general hospital. Br Med J (1957) 0.85
Actions of dopamine antagonists on stimulated striatal and limbic dopamine release: an in vivo voltammetric study. Br J Pharmacol (1988) 0.85
The use of chlorpromazine in anesthesia and surgery. Ann Surg (1955) 0.85
Jaundice occurring during the administration of chlorpromazine. Can Med Assoc J (1955) 0.84
Drugs used in the management of epilepsy. Proc R Soc Med (1957) 0.83
Unique pharmacological actions of atypical neuroleptic quetiapine: possible role in cell cycle/fate control. Transl Psychiatry (2013) 0.83
Tranquillizers and other psychotropic drugs in clinical practice. Can Med Assoc J (1958) 0.82
Chlorpromazine and insulin in psychiatry. Br Med J (1954) 0.82
Who pioneered the use of antipsychotics in north america? Can J Psychiatry (2015) 0.80
Effects of promazine in mental syndromes. Can Med Assoc J (1957) 0.76
Epigenetic signaling in schizophrenia. Cell Signal (2015) 0.76
Psychiatric experiences with plexonal. Can Med Assoc J (1954) 0.75
Chlorpromazine and allied substances. Postgrad Med J (1955) 0.75
Liver damage following the use of chlorpromazine (thorazine). J Natl Med Assoc (1956) 0.75
Magic bullets for mental disorders: the emergence of the concept of an "antipsychotic" drug. J Hist Neurosci (2013) 0.75
The 10th anniversary of the eli lilly chair of schizophrenia from the university of montreal. Can J Psychiatry (2015) 0.75
Phenothiazine drugs and the general practitioner. Can Med Assoc J (1962) 0.75
The treatment of depressive conditions with imipramine (G 22355). Can Psychiatr Assoc J (1958) 3.70
Therapeutic trial of iproniazid (marsilid) in depressed and apathetic patients. Can Med Assoc J (1958) 1.44
Therapeutic results with chlorpromazine (largactil) in psychiatric conditions. Can Med Assoc J (1955) 1.17
New drugs in psychiatric therapy. Can Med Assoc J (1961) 1.14
Experimental sleep deprivation in schizophrenic patients. AMA Arch Gen Psychiatry (1960) 1.06
Clinical observations with frenquel in chronic schizophrenia. Can Psychiatr Assoc J (1956) 0.95
Observations on the action of Sernyl-a new psychotropic drug. Can Psychiatr Assoc J (1961) 0.93
Differential screening of phrenotropic agents in man: psychophysiologio test data. J Clin Exp Psychopathol (1958) 0.91
USE AND ABUSE OF PHENOTHIAZINES. Appl Ther (1963) 0.87
SKIN PIGMENTATION, A RARE SIDE EFFECT OF CHLORPROMAZINE. Can Psychiatr Assoc J (1965) 0.86
Clinical trial with desmethylimipramine (G-35020), a new antidepressive compound. Can Med Assoc J (1962) 0.85
Placebo-proneness and placebo-resistance of different psychological functions. Psychiatr Q (1960) 0.85
[An inhibiting drug for control and treatment of psychomotoric states of excitability (chlorpromazine, largactil, thorazine, megaphen)]. Nervenarzt (1954) 0.82
Perphenazine; observations on the clinical effects of a new tranquillizing agent in psychotic conditions. Can Psychiatr Assoc J (1957) 0.82
Tranquillizers and other psychotropic drugs in clinical practice. Can Med Assoc J (1958) 0.82
THE PHARMACOTHERAPY OF THE DEPRESSIVE SYNDROME. Can Med Assoc J (1965) 0.80
[RELATION BETWEEN PHOTOSENSITIVITY AND PATHOLOGIC PIGMENTATION OF THE SKIN WITH HIGH DOSES OF CHLORPROMAZINE]. Union Med Can (1965) 0.80
The eosinophil response to ACTH in the manic phase of manic depressive psychosis. Can Med Assoc J (1950) 0.78
Three cases of disseminated lupus erythematosus with psychosis. Can Med Assoc J (1954) 0.78
Combined pharmaco-fever treatment with imipramine (tofranil) and typhoid vaccine in the management of depressive conditions. Am J Psychiatry (1960) 0.78
NOTES FROM THE LOG-BOOK OF A PSYCHOPHARMACOLOGICAL RESEARCH UNIT. II. Can Psychiatr Assoc J (1964) 0.77
Psychiatric concepts of depression: nomenclature and classification. Can Psychiatr Assoc J (1959) 0.76
Phenomenology and pathology of addiction. Compr Psychiatry (1963) 0.75
The Centre de Psychiatrie in Haiti. Psychopharmacol Serv Cent Bull (1962) 0.75
Developmental norms on four psychophysiological measures for use in the evaluation of psychotic disorders. Can J Psychol (1958) 0.75
Studies on the iron content of cerebrospinal fluid in different psychotic conditions. AMA Arch Neurol Psychiatry (1951) 0.75
Methods of evaluation of drug effects on the human central nervous system. Res Publ Assoc Res Nerv Ment Dis (1959) 0.75
Further studies on the iron content of the cerebrospinal fluid in psychoses. AMA Arch Neurol Psychiatry (1952) 0.75
Psychoactive drugs and their influence on the dynamics of working capacity. J Occup Med (1960) 0.75
A COMPARATIVE STUDY OF THIRTEEN HYPNOTIC DRUGS. Appl Ther (1964) 0.75
PSYCHOPHARMACOLOGY. A DISCUSSION OF CURRENT PROBLEMS. Ohio State Med J (1963) 0.75
THE PLACEBO RESPONSE AND THE DOUBLE-BLIND STUDY. Proc Annu Meet Am Psychopathol Assoc (1964) 0.75
POTENTIATION OF PHARMACOLOGICAL AND THERAPEUTIC ACTION OF PHENOTHIAZINES BY NYLIDRIN (ARLIDIN). Compr Psychiatry (1964) 0.75
Stress dynamics in psychiatric perspective. Psychiatry (1952) 0.75
A dynamic concept of the action of chlorpromazine at physiological and psychological levels. Encephale (1956) 0.75
Attempt to classify psychotropic drugs, based on their affinity to mucopolysaccharides in vivo. J Clin Exp Psychopathol Q Rev Psychiatry Neurol (1962) 0.75
The psychopharmacological profile--a systematic approach to the interaction of drug effects and personality traits. Rev Can Biol (1961) 0.75
Studies on psychiatric patients undergoing nitrous oxide treatments. J Ment Sci (1950) 0.75
NOTES FROM THE LOG-BOOK OF A PSYCHOPHARMACOLOGICAL RESEARCH UNIT I. Can Psychiatr Assoc J (1964) 0.75
RATING THE RATER. AN EXPERIMENTAL APPROACH TO THE METHODOLOGICAL PROBLEM OF INTERRATER AGREEMENT. Arch Gen Psychiatry (1965) 0.75
Neurophysiologic activity of chlorpromazine in clinical use. J Clin Exp Psychopathol (1956) 0.75
Discussion: Pavlovian Conference on Higher Nervous Activity. V. Psychopharmacology. Ann N Y Acad Sci (1961) 0.75
The use of finger paintings in the clinical evaluation of psychotic conditions: a quantitative and qualitative approach. J Ment Sci (1953) 0.75
Socio-psychiatric observations on displaced persons. Psychiatr Q Suppl (1953) 0.75
The effect of clopenthixol on chronic psychiatric patients. Am J Psychiatry (1963) 0.75
New effective drugs in psychiatric therapy. Can Nurse (1962) 0.75